On October 19th 2023, Charlotte Derpoorter successfully defended her PhD dissertation “Childhood cancer predisposition: exploring missing heritability using DNA sequencing approaches”.
We introduced a test that improves the treatment of children with acute lymphocytic leukemia (ALL), the most common childhood cancer.
The test tells us very quickly whether or not a treatment is working. We now apply it to all children with ALL in Belgium. Since January 2023, he has also been reimbursed by the Riziv.
The test was made possible thanks to the support of Kom op tegen Kanker (non-profit organization) and the Children’s Cancer Fund.